These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 3444369

  • 21. Conversion of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine to 1-O-alk-1'-enyl-2-acyl-sn-glycero-3-phosphoethanolamine. A novel pathway for the metabolism of ether-linked phosphoglycerides.
    Strum JC, Emilsson A, Wykle RL, Daniel LW.
    J Biol Chem; 1992 Jan 25; 267(3):1576-83. PubMed ID: 1309787
    [Abstract] [Full Text] [Related]

  • 22. Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3).
    Shames R, Ruis NM, Valone FH.
    Int J Immunopharmacol; 1994 Apr 25; 16(4):335-43. PubMed ID: 8045673
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
    Bittman R, Witzke NM, Lee TC, Blank ML, Snyder F.
    J Lipid Res; 1987 Jun 25; 28(6):733-8. PubMed ID: 3611974
    [Abstract] [Full Text] [Related]

  • 24. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
    Danhauser S, Berdel WE, Schick HD, Fromm M, Reichert A, Fink U, Busch R, Eibl H, Rastetter J.
    Lipids; 1987 Nov 25; 22(11):911-5. PubMed ID: 3444384
    [Abstract] [Full Text] [Related]

  • 25. Ether lipids inhibit the effects of phorbol diester tumor promoters.
    Daniel LW, Etkin LA, Morrison BT, Parker J, Morris-Natschke S, Surles JR, Piantadosi C.
    Lipids; 1987 Nov 25; 22(11):851-5. PubMed ID: 3444377
    [Abstract] [Full Text] [Related]

  • 26. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
    Alonso MT, Gajate C, Mollinedo F, Modolell M, Alvarez J, García-Sancho J.
    Br J Pharmacol; 1997 Aug 25; 121(7):1364-8. PubMed ID: 9257915
    [Abstract] [Full Text] [Related]

  • 27. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C.
    Sawai H, Domae N, Nagan N, Hannun YA.
    J Biol Chem; 1999 Dec 31; 274(53):38131-9. PubMed ID: 10608884
    [Abstract] [Full Text] [Related]

  • 28. Specificity of lysophospholipase D.
    Wykle RL, Kraemer WF, Schremmer JM.
    Biochim Biophys Acta; 1980 Jul 14; 619(1):58-67. PubMed ID: 7417469
    [Abstract] [Full Text] [Related]

  • 29. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V, Mascarucci P, De Simoni MG, Jiang X, Bindoni M.
    Cytokine; 1996 Sep 14; 8(9):698-701. PubMed ID: 8932980
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 31. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML, Spector AA, Kaduce TL, Lee TC, Snyder F.
    Biochim Biophys Acta; 1986 May 21; 876(3):373-8. PubMed ID: 3707974
    [Abstract] [Full Text] [Related]

  • 32. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb 21; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 33. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Gajate C, Santos-Beneit A, Modolell M, Mollinedo F.
    Mol Pharmacol; 1998 Apr 21; 53(4):602-12. PubMed ID: 9547349
    [Abstract] [Full Text] [Related]

  • 34. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H, Kudo I, Inoue K, Onozaki K, Tsushima S, Nomura H, Nojima S.
    J Biochem; 1985 Jun 21; 97(6):1737-45. PubMed ID: 2993272
    [Abstract] [Full Text] [Related]

  • 35. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
    Blank ML, Smith ZL, Fitzgerald V, Snyder F.
    Biochim Biophys Acta; 1995 Feb 09; 1254(3):295-301. PubMed ID: 7857969
    [Abstract] [Full Text] [Related]

  • 36. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
    Bishop FE, Dive C, Freeman S, Gescher A.
    Cancer Chemother Pharmacol; 1992 Feb 09; 31(2):85-92. PubMed ID: 1451237
    [Abstract] [Full Text] [Related]

  • 37. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
    Kudo I, Nojima S, Chang HW, Yanoshita R, Hayashi H, Kondo E, Nomura H, Inoue K.
    Lipids; 1987 Nov 09; 22(11):862-7. PubMed ID: 3444379
    [Abstract] [Full Text] [Related]

  • 38. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, Mayhew E.
    Cancer Res; 1997 May 15; 57(10):1915-21. PubMed ID: 9157985
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR, Bittman R, Peters A, Mayhew E.
    J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and antineoplastic properties of an ether glycerophosphonocholine, and analog of ET-18-OCH3-GPC.
    Salari H, Howard S, Bittman R.
    Biochem Biophys Res Commun; 1992 Sep 16; 187(2):603-8. PubMed ID: 1530618
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.